As important developments in the effort to create a low-power portable lab-on-a-chip system, we demonstrate the concentration of human CD8+ T-lymphocytes on an electrowetting-on-dielectric (EWOD) platform using antibody-conjugated magnetic beads (MB-Ab). This is an important step of the protocol used to monitor the risk of rejection in organ transplant patients.
INTRODUCTION
The ability to concentrate and separate specific cells is critical for cell-based biological assays and medical diagnostics. For instance, CD8+ cytotoxic T-lymphocytes play a critical role in transplantrejection by infiltrating the transplanted organs and releasing proteins that attract additional lymphocytes to destroy the transplant cells. If CD8+ lymphocytes could be isolated from other peripheral blood components and then lysed, the concentration of these cells and their associated proteins could be measured to diagnose rejection non-invasively [1, 2] . While this protocol is well-established at the UCLA Immunogenetics Center, the transplanted patients have to visit the center for the tests. A portable device performing the lab test would not only obviate the post-transplantation visits but also facilitate early diagnosis and timely treatment. With its simplicity and low power-consumption, electrowetting-on-dielectric (EWOD)-based digital microfluidics is promising for such a point-of-care device.
In the quest to realize the entire lab protocol on a portable system, we report two main steps realized on the EWOD platform. First, we developed and quantitatively assessed binding of CD8+ cells to MB-Abs. Second, we developed the ability to separate CD8+ lymphocytes from a mixture of CD8+ and CD8-lymphocytes. While recent studies have shown concentration of MBs on EWOD platform is feasible in principle using simple water containing only the beads [3] [4] [5] , this is the first report of success in advancing the concept to living cells.
MATERIALS AND METHODS

Cells Sample Preparation
Lymphocytes were isolated from whole blood using standard hematological procedures. Peripheral blood mononuclear cells were separated over a Ficoll-Hypaque gradient. Lymphocytes were obtained after macrophage depletion by adherence to a plastic flask. CD8+ and CD8-lymphocytes were separated using anti-CD8 MB-Ab (Dynabeads CD8 Positive Isolation Kit from Invitrogen, Inc., CA) before being detached from the MB's. Before EWOD experiments, the cells were spun down and resuspended in serum-free buffer. For visualization, the CD8+ cells were stained with fluorescent dye (CFSE).
EWOD Device Fabrication
Typical UCLA EWOD fabrication processes [3] were used to prepare the device (Fig. 1) . EWOD electrodes were defined on an Indium-Tin Oxide (ITO) (1400Ǻ) layer over a 700 µm-thick glass ("EWOD") substrate (TechGophers Inc.) . Cr/Au (~100/1000 Ǻ) was deposited and patterned to define the contact pads and electrode labels for easier visualization. Next, a Si 3 N 4 layer (~1 µm) was deposited using PECVD, and patterned to define the dielectric layer. A Cytop ® (Asahi Inc.) layer (~1 µm) was spincoated on top, and annealed at 200 o C to make the surface hydrophobic. 1.1 mm-thick glass substrates coated with ITO (1400 Ǻ) (Delta Technologies Inc.) were used to fabricate the "Reference" substrate. A thinner PECVD Si 3 N 4 layer (~1000 Ǻ) was deposited and patterned on it to expose the ITO for electrical ground connection, followed by Cytop ® spin-coating and annealing (~1000 Ǻ). A double-sided tape (~100 µm thick, 3M Inc.) was used as the spacer between the substrates.
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Device Actuation and Image Capture
Droplet actuation was achieved by application of voltage (~70 Vac 1 kHz) to EWOD electrodes. Electronic control for the actuation sequence was controlled using LabVIEW (National Instruments Inc.) with the help of a digital I/O device (DAQPad 6507, National Instruments). Magnetic force was provided using a cylindrical permanent magnet (NdFeB, ½" dia. ½" thick) placed on top of the EWOD substrate (Fig. 1) .
The device was mounted on an inverted fluorescence microscope (Nikon TE-2000U) for visualization. A video camera (Panasonic KR-222) was used to capture the droplet actuation movies, while still optical and fluorescence images were taken using a cooled CCD camera (Photometrics Coolsnap EZ).
RESULTS AND DISCUSSION
Flow cytometry Experiments
Before doing experiments on EWOD, the assay was verified using the conventional laboratory techniques. Flow-cytometry measurements were performed to determine the isolation efficiency for cell separation according to protocol. To ensure that MB-cell binding will also occur on an EWOD device, cell separation was also performed for binding conditions similar to EWOD (e.g. room temperature instead of the prescribed 2-8ºC). Fig. 2 shows that CD8+ isolation efficiency was similarly high (>95%) under both conditions (Fig. 2 middle, right) .
Cell-MB Binding on EWOD
The steps to evaluate CD8+ cells binding with MBs on the EWOD device are schematically described in Fig. 3 and demonstrated in Fig. 4 . A droplet containing MB-Ab (~10 7 /ml) and another containing fluorescently stained CD8+ cells (~10 5 /ml) were merged using EWOD (Figs. 3(a, b), 4(a, b) ). The combined droplet was moved repeatedly over a circular path of electrodes to allow MB-cell mixing. After about 8-10 minutes (Fig. 3(c, d), 4(c, d) ), an NdFeB magnet was introduced (Fig. 3(e), 4(e) (Los Angeles, CA) used here eliminates the need for either of these.) The droplet is subsequently cut to form the collected droplet (left) and the depleted droplet (right) (Fig. 5(a, b) ).
By manually counting the fluorescent cells in these droplets, the cell-collection efficiency is conservatively estimated to be >92% (Fig. 5(c-f) ). (Some cells in the collected droplet may be hidden behind MBs.). This high efficiency is attributed to the high interaction between MBs and cells confined inside a circulating droplet, as compared to a flow-through channel-microfluidics system.
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Figure 3: Schematic description of binding cells to MBs and concentration of the cells on EWOD platform. (a, b) A droplet containing MBs and another containing cells are merged. (c, d) Merged droplet is repeatedly moved around using EWOD along a circular path to mix the MBs and cells. (e) Magnet pulls MBs to the left end, along with the bound cells.
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